Medimmune News (NASDAQ:MEDI)
| Latest Medimmune News Headlines | | Date | Time | Source | | | 05/25/2007 | 5:00PM | PRNUS | MedImmune Receives Correspondence From FDA Regarding FluMist(R)
GAITHERSBURG, Md., May 25 /PRNewswire-FirstCall/ -- MedImmune, Inc. (NASDAQ:MEDI) announced today that the U.S. Food and Drug Administration (FDA) has stated the agency has completed its review of all submissions made related to the supplemental biologics license application (sBLA) to extend the age indication of FluMist(R... More...>> |
| 05/24/2007 | 11:30AM | PRNUS | MedImmune Highlights Advances in Inflammatory Disease Pipeline With Series of Data Presentations
Data Include Results from Phase 1 Studies with Monoclonal Antibody Targeting Interleukin-9 (IL-9); Preclinical Data Provide Further Rationale for IL-9 Inhibition in Developing Potential Asthma Therapies
GAITHERSBURG, Md., May 24 /PRNewswire-FirstCall/ -- MedImmune, Inc. (NASDAQ:MEDI) today announced the presentation... More...>> |
| 05/24/2007 | 11:30AM | PRNUS | Anti-Interleukin-9 Data Presented at the American Thoracic Society Meeting
PLYMOUTH MEETING, Penn., May 24 /PRNewswire-FirstCall/ -- Genaera Corporation (NASDAQ:GENR) today reported that MedImmune, Inc. (NASDAQ:MEDI) presented data related to the Interleukin-9 (IL-9) program at the American Thoracic Society (ATS) 2007 Annual Conference held May 18-23 in San Francisco, California. Genaera and... More...>> |
| 05/16/2007 | 3:17PM | PRNUS | FDA Advisory Committee Recommends Expanded Use of FluMist(R)
GAITHERSBURG, Md., May 16 /PRNewswire-FirstCall/ -- MedImmune, Inc. (NASDAQ:MEDI) today announced that the U.S. Food and Drug Administration's (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted in favor of expanding the population for use of FluMist (Influenza Virus Vaccine Live, Intranasal... More...>> |
| 05/08/2007 | 2:30PM | PRNUS | Data Show FluMist(R) May Reduce Seasonal Influenza Burden Among Children in School, Daycare Settings
New Economic Analyses of School and Daycare Study Outcomes Suggest Vaccinating Against Influenza May Produce Cost Savings for Community at Large
TORONTO, May 8 /PRNewswire-FirstCall/ -- MedImmune, Inc. (NASDAQ:MEDI) announced today research results showing that use of FluMist(R) (Influenza Virus Vaccine Live, Intranasal... More...>> |
| 05/08/2007 | 12:01PM | PRNUS | MedImmune Announces Positive Clinical Results at PAS Annual Meeting From Large Prospective Trial in Prevention of Serious RSV Di
- Numax Achieves Primary Endpoint Among High-Risk Infants Versus Current Standard of Care and Shows Reduction of Medically Attended Outpatient RSV- Related Lower Respiratory Infections -
TORONTO, May 8 /PRNewswire-FirstCall/ -- MedImmune, Inc. (NASDAQ:MEDI) today announced positive results from a large prospective trial... More...>> |
| 05/07/2007 | 10:25AM | PRNUS | MedImmune Provides Fellowship Grants To Six Pediatric Respiratory Researchers
- Archana Singh, M.D., Winthrop University Hospital, Receives $35,000 Grant -
TORONTO, May 7 /PRNewswire-FirstCall/ -- Underscoring its commitment to pediatric medicine, MedImmune, Inc. (NASDAQ:MEDI) has divided a 2007 grant for $210,000 for pediatric respiratory research among six pediatric fellows; each recipient's... More...>> |
| 05/07/2007 | 10:14AM | PRNUS | MedImmune Provides Fellowship Grants To Six Pediatric Respiratory Researchers
- Victoria McMeen, M.D., University of Virginia, Receives $35,000 Grant -
TORONTO, May 7 /PRNewswire-FirstCall/ -- Underscoring its commitment to pediatric medicine, MedImmune, Inc. (NASDAQ:MEDI) has divided a 2007 grant for $210,000 for pediatric respiratory research among six pediatric fellows; each recipient's institution... More...>> |
| 05/07/2007 | 10:05AM | PRNUS | MedImmune Provides Fellowship Grants To Six Pediatric Respiratory Researchers
- Jayson Luma, M.D., The Women's and Children's Hospital of Buffalo, Receives $35,000 Grant -
TORONTO, May 7 /PRNewswire-FirstCall/ -- Underscoring its commitment to pediatric medicine, MedImmune, Inc. (NASDAQ:MEDI) has divided a 2007 grant for $210,000 for pediatric respiratory research among six pediatric fellows;... More...>> |
| 05/07/2007 | 10:00AM | PRNUS | MedImmune Provides Fellowship Grants To Six Pediatric Respiratory Researchers
- Steven Grube, M.D., University of Texas Southwestern Medical School, Receives $35,000 Grant -
TORONTO, May 7 /PRNewswire-FirstCall/ -- Underscoring its commitment to pediatric medicine, MedImmune, Inc. (NASDAQ:MEDI) has divided a 2007 grant for $210,000 for pediatric respiratory research among six pediatric fellows;... More...>> |
| 05/07/2007 | 10:00AM | PRNUS | MedImmune Provides Fellowship Grants to Six Pediatric Respiratory Researchers
- Michele Kong, M.D., University of Alabama at Birmingham, Receives $35,000 Grant -
TORONTO, May 7 /PRNewswire-FirstCall/ -- Underscoring its commitment to pediatric medicine, MedImmune, Inc. (NASDAQ:MEDI) has divided a 2007 grant for $210,000 for pediatric respiratory research among six pediatric fellows; each recipient's... More...>> |
| 05/07/2007 | 10:00AM | PRNUS | MedImmune Provides Fellowship Grants To Six Pediatric Respiratory Researchers
- Laura Hammitt, M.D., The Children's Hospital/University of Colorado Health Sciences Center, Receives $35,000 Grant -
TORONTO, May 7 /PRNewswire-FirstCall/ -- Underscoring its commitment to pediatric medicine, MedImmune, Inc. (NASDAQ:MEDI) has divided a 2007 grant for $210,000 for pediatric respiratory research among... More...>> |
| 05/07/2007 | 9:30AM | PRNUS | MedImmune and Pediatric Infectious Diseases Society Present 2007 Career Development Award and Viral Respiratory Disease Fellowsh
TORONTO, May 7 /PRNewswire-FirstCall/ -- The Pediatric Infectious Diseases Society (PIDS), supported by grants from MedImmune, Inc. (NASDAQ:MEDI), will present the third annual MedImmune Career Development Award in Pediatric Infectious Disease to Jin-Young Han, M.D., Ph.D., from the University of Minnesota and the second... More...>> |
| 05/02/2007 | 3:31PM | PRNUS | MedImmune, Inc. Announces Convertibility of 1.375% Convertible Senior Notes Due 2011 and 1.625% Convertible Senior Notes Due 201
GAITHERSBURG, Md., May 2 /PRNewswire-FirstCall/ -- MedImmune, Inc. (NASDAQ:MEDI) today announced that, in connection with the previously disclosed pending acquisition of MedImmune by AstraZeneca PLC pursuant to a "first-step" cash tender offer by an indirect wholly owned subsidiary of AstraZeneca PLC for all outstanding... More...>> |
| 05/02/2007 | 8:15AM | PRNUS | Pediatric Academic Societies' Annual Meeting to Feature Data Presentations Related to MedImmune Clinical Programs in Influenza,
GAITHERSBURG, Md., May 2 /PRNewswire-FirstCall/ -- MedImmune, Inc. (NASDAQ:MEDI) today announced that seven abstracts will be presented at the 2007 Pediatric Academic Societies' (PAS) Annual Meeting demonstrating the company's commitment to advancing the science of pediatric medicine. Data are from studies pertaining... More...>> |
| 04/30/2007 | 5:30PM | PRNUS | MedImmune Reports Financial Results for 2007 First Quarter
GAITHERSBURG, Md., April 30 /PRNewswire-FirstCall/ -- MedImmune, Inc. (NASDAQ:MEDI) announced today that a 15-percent increase in total revenues and a substantial increase in net income margin drove the company's net earnings for the 2007 first quarter up more than three-fold over the year-ago quarter. In the 2007... More...>> |
| 04/19/2007 | 7:30AM | PRNUS | MedImmune and Micromet Publish Data on Novel Anti-Cancer BiTE(R) Molecule
- New Compound Targeting Receptor Tyrosine Kinase EphA2 Shows Tumor Destruction at Low Dose Levels in Preclinical Models -
GAITHERSBURG, Md. and CARLSBAD, Calif., April 19 /PRNewswire-FirstCall/ -- MedImmune, Inc. (NASDAQ:MEDI) and Micromet, Inc. (NASDAQ:MITI) today announced that published proof-of-concept data with... More...>> |
| 04/18/2007 | 4:00PM | PRNUS | MedImmune Publishes New Data in Nature Immunology Demonstrating The Role HMGB1 May Play in Systemic Autoimmune Diseases
- Preclinical Data Support Rationale for Targeting Pro-Inflammatory Protein -
GAITHERSBURG, Md., April 18 /PRNewswire-FirstCall/ -- MedImmune, Inc. (NASDAQ:MEDI) today announced the publication of preclinical study data demonstrating a role for high mobility group box protein-1 (HMGB1), a nuclear DNA-binding protein... More...>> |
| 04/18/2007 | 12:05PM | PRNUS | Micromet and MedImmune Present Data From Preclinical Study of New BiTE(R) Molecule Targeting CEA
GAITHERSBURG, Md. and CARLSBAD, Calif., April 18 /PRNewswire-FirstCall/ -- Micromet, Inc. (NASDAQ:MITI) and MedImmune, Inc. (NASDAQ:MEDI) today announced data from a preclinical study in which BiTE(R) molecules targeting carcinoembryonal antigen (CEA) were shown to prevent subcutaneous tumor growth and formation of... More...>> |
| 04/16/2007 | 9:45AM | PRNUS | Icahn Comments on MedImmune Sale Process
New York, April 16 /PRNewswire/ -- Several weeks ago, as a large shareholder of MedImmune, Inc. (NASDAQ:MEDI), Carl Icahn informed the company that, because of lackluster performance over the last four or five years, he believed the best course of action was to put the company up for sale and that he intended to nominate... More...>> |
|
|
|